But that only about 5 % quit after entering prenatal care.

The study found that almost half of pregnant stop New Jersey smoker smoking before entry into prenatal care, but that only about 5 % quit after entering prenatal care. Even worse, although prenatal care providers asked almost every woman entering prenatal care if they smoke, only 56.7 % reported that a provider advised them to quit smoking, said lead author Van Tong, of the Centers for Disease Control and Prevention. More work is needed to increase the knowledge, promotion and provision of effective cessation programs for pregnant women, and, ideally, to prevent young women ever initiated smoking, she said.

The researchers analyzed questionnaire data from 4 tobacco use inen in Pregnancy Risk Assessment Monitoring System in New Jersey from 2004 to 2005. They chose New Jersey because the state survey respondents has any questions about smoking behavior and use of cessation services. The study appears in the October issue of the American Journal of Preventive Medicine.Located on complex diseases that profit from the high performance analysis, including genotyping, copy number of, gene, methylation and protein analysis of .. 510 Receives FDA 510 clearance of his BeadXpress multiplexing Analysis system of.

Illumina today announced that the U.S. Food and Drug Administration was 510 market clearance analyzing take for granted the company BeadXpress to division multiplex genetic. According to the with FDA indications for the usage that BeadXpress system – one in IVD device of the simultaneous determination of several analytes in a DNA sample using VeraCode the holographic microbead technologies determines – consisting Illumina BeadXpress Reader and causing scanner software.

Other Posts From Category "specialist":

Related Posts